Gem of the day

The concept of an 'Access to Medicine Index', comparing how well the world's big pharmaceutical companies are doing at providing people in developing countries with affordable drugs, could be just the shake-up this industry needs. Novartis continues its 6-year battle with the Indian government over pricing and patents, and GSK is still reeling from its record $3 billion settlement with the US government for fraud and civil liabilities (read: mislabeling drugs and covering up evidence in medical journals).

Instead, here's the quote the founder of the index chose to provide to sum up the challenge at hand (via The Guardian):

"Access to medicine is a multi-faceted challenge and therefore responsibility for improving it lies with a number of different actors, but the pharmaceutical industry has a critical role to play."

No comments:

Post a Comment